Literature DB >> 10854381

Family reports of pain in dying hospitalized patients: a structured telephone survey.

S W Tolle1, V P Tilden, S E Hickman, A G Rosenfeld.   

Abstract

OBJECTIVES: To see how often families in Oregon reported moderate to severe pain in dying patients in late 1998 compared with late 1997.
DESIGN: A systematic random sample of death certificates was used to identify family members of decedents who died in a hospital setting between October 1 and December 31, 1998. A structured telephone interview was used to obtain data. PARTICIPANTS: Family members of 103 decedents (who died in hospitals 2 to 4 months before data collection) were identified with the use of death certificates.
RESULTS: In late 1998, 56 family members (54%) reported that their loved one experienced moderate to severe pain in the last week of life.
CONCLUSIONS: Family reports of moderate to severe pain in dying hospitalized Oregonians remain high. The influence of environmental factors on pain management may have implications for practice and policy nationwide.

Entities:  

Mesh:

Year:  2000        PMID: 10854381      PMCID: PMC1070920          DOI: 10.1136/ewjm.172.6.374

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  12 in total

1.  Family reports of barriers to optimal care of the dying.

Authors:  S W Tolle; V P Tilden; A G Rosenfeld; S E Hickman
Journal:  Nurs Res       Date:  2000 Nov-Dec       Impact factor: 2.381

Review 2.  Regulatory barriers to pain management.

Authors:  D E Joranson; A M Gilson
Journal:  Semin Oncol Nurs       Date:  1998-05       Impact factor: 2.315

3.  Oregon's assisted suicide vote: the silver lining.

Authors:  M A Lee; S W Tolle
Journal:  Ann Intern Med       Date:  1996-01-15       Impact factor: 25.391

4.  Pain and pain relief experienced by hospice patients with cancer.

Authors:  S C McMillan
Journal:  Cancer Nurs       Date:  1996-08       Impact factor: 2.592

5.  A prospective study of the efficacy of the physician order form for life-sustaining treatment.

Authors:  S W Tolle; V P Tilden; C A Nelson; P M Dunn
Journal:  J Am Geriatr Soc       Date:  1998-09       Impact factor: 5.562

6.  Pain and treatment of pain in minority patients with cancer. The Eastern Cooperative Oncology Group Minority Outpatient Pain Study.

Authors:  C S Cleeland; R Gonin; L Baez; P Loehrer; K J Pandya
Journal:  Ann Intern Med       Date:  1997-11-01       Impact factor: 25.391

7.  A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators.

Authors: 
Journal:  JAMA       Date:  1995 Nov 22-29       Impact factor: 56.272

Review 8.  Doctors, opioids, and the law: the effect of controlled substances regulations on cancer pain management.

Authors:  D E Weissman
Journal:  Semin Oncol       Date:  1993-04       Impact factor: 4.929

9.  Model policy for the use of controlled substances for the treatment of pain.

Authors: 
Journal:  J Pain Palliat Care Pharmacother       Date:  2005

10.  Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology.

Authors:  R Bernabei; G Gambassi; K Lapane; F Landi; C Gatsonis; R Dunlop; L Lipsitz; K Steel; V Mor
Journal:  JAMA       Date:  1998-06-17       Impact factor: 56.272

View more
  3 in total

1.  Opportunity lost: end-of-life discussions in cancer patients who die in the hospital.

Authors:  Mark C Zaros; J Randall Curtis; Maria J Silveira; Joann G Elmore
Journal:  J Hosp Med       Date:  2012-11-20       Impact factor: 2.960

2.  The quality of care provided to hospitalized patients at the end of life.

Authors:  Anne M Walling; Steven M Asch; Karl A Lorenz; Carol P Roth; Tod Barry; Katherine L Kahn; Neil S Wenger
Journal:  Arch Intern Med       Date:  2010-06-28

3.  Pain in amyotrophic lateral sclerosis: a neglected aspect of disease.

Authors:  Chalonda R Handy; Christina Krudy; Nicholas Boulis; Thais Federici
Journal:  Neurol Res Int       Date:  2011-05-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.